ペンシルベニアにおける前立腺がんの臨床試験
ペンシルベニア内の拠点で、前立腺がんに関する64件の研究が参加者を募集しています。
ペンシルベニア内の都市
- Philadelphia44件の研究
- Pittsburgh23件の研究
- Harrisburg8件の研究
- Scranton5件の研究
- York5件の研究
- Erie5件の研究
- Hazleton4件の研究
- Lancaster4件の研究
- Reading4件の研究
- Chambersburg3件の研究
- Allentown3件の研究
公式研究テキスト（英語）
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
- WellSpan York Cancer Center, York
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Saint Vincent Hospital, Erie
- Jefferson Hospital, Jefferson Hills
- Forbes Hospital, Monroeville
- 他8件
被験者募集中第3相
18歳以上 · 男性 · 2026/10/02更新 · NCT06931340Distance-Based Exercise to Preserve Function and Prevent Disability
- UPMC Hillman Cancer Center at Butler Health System, Butler
- IRMC Cancer Center, Indiana
- UPMC Hillman Cancer Center - New Castle, New Castle
- 他2件
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Geisinger Medical Center, Danville
- 他7件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Pocono Medical Center, East Stroudsburg
- 他8件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
被験者募集中第1相
18歳以上 · 男性 · 2026/09/28更新 · NCT06095089A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- MidLantic urology ( Site 0022), Bala-Cynwyd
- Fox Chase Cancer Center ( Site 0076), Philadelphia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- MidLantic urology, Bala-Cynwyd
- The Centers for Advanced Urology d/b/a Keystone Urology Specialist, Lancaster
被験者募集中第3相
18歳以上 · 男性 · 2026/09/24更新 · NCT07028853Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Fox Chase Cancer Center, Philadelphia
被験者募集中第2/3相
18歳〜100歳 · 男性 · 2026/09/22更新 · NCT06780670A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- University of Pittsburgh Medical Center, Pittsburgh
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Pittsburgh Medical Center, Pittsburgh
被験者募集中第3相
18歳以上 · 男性 · 2026/09/22更新 · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Hershey
- Research Site, Lancaster
- Research Site, Pittsburgh
被験者募集中第3相
18歳以上 · 男性 · 2026/09/18更新 · NCT06952803Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
被験者募集中第2相
18歳以上 · 男性 · 2026/09/17更新 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Perelman Center for Advanced Medicine ( Site 0067), Philadelphia
- Abramson Cancer Center - Penn Medicine ( Site 0079), Philadelphia
被験者募集中第3相
18歳以上 · 男性 · 2026/09/17更新 · NCT06925737First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- GSK Investigational Site, Philadelphia
被験者募集中第1/2相
18歳以上 · 男性 · 2026/09/16更新 · NCT07332455Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Thomas Jefferson University, Philadelphia
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
被験者募集中第1相
18歳以上 · 男性 · 2026/09/15更新 · NCT07493512Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- MidLantic Urology, Bala-Cynwyd
被験者募集中
18歳以上 · 男性 · 2026/09/14更新 · NCT06511141Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- UPMC-Heritage Valley Health System Beaver, Beaver
- Carlisle Regional Cancer Center, Carlisle
- Christiana Care Health System-Concord Health Center, Chadds Ford
- 他24件
被験者募集中第3相
18歳以上 · 男性 · 2026/09/10更新 · NCT05946213Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
- Wellspan, Chambersburg
被験者募集中
18歳以上 · 全性別 · 2026/09/03更新 · NCT06138067A Study of Tarlatamab for People With Prostate Cancer
- Thomas Jefferson University Hospital, Philadelphia
被験者募集中第2相
18歳以上 · 男性 · 2026/08/31更新 · NCT07111507Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
- Penn State Cancer Institute, Hershey
被験者募集中第1/2相
40歳以上 · 男性 · 2026/08/31更新 · NCT06600698AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Pittsburgh
被験者募集中第3相
18歳以上 · 男性 · 2026/08/26更新 · NCT07611110Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Lancaster Urology, Lancaster
被験者募集中第2相
18歳以上 · 男性 · 2026/08/24更新 · NCT07745361A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia
被験者募集中第2相
18歳以上 · 男性 · 2026/08/21更新 · NCT06844383Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Thomas Jefferson University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
被験者募集中第1相
18歳以上 · 男性 · 2026/08/21更新 · NCT04221542Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- UPMC Altoona, Altoona
- UPMC-Heritage Valley Health System Beaver, Beaver
- Carlisle Regional Cancer Center, Carlisle
- 他26件
被験者募集中第3相
18歳以上 · 男性 · 2026/08/19更新 · NCT04423211FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Penn State Milton S. Hershey Medical Center, Hershey
- Thomas Jefferson University Honickman Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第1相
18歳〜100歳 · 男性 · 2026/08/13更新 · NCT05519449Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Thomas Jefferson University, Philadelphia
被験者募集中第1相
18歳以上 · 男性 · 2026/07/31更新 · NCT06613100Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #109, Philadelphia
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/23更新 · NCT06545942PSMA PET Combined With MRI for the Detection of PCa
- MidLantic Urology, Philadelphia
被験者募集中第3相健康なボランティア歓迎
18歳以上 · 男性 · 2026/07/23更新 · NCT07052214Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Christiana Care Health System-Concord Health Center, Chadds Ford
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- 他6件
被験者募集中第3相
18歳以上 · 男性 · 2026/07/14更新 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- MidLantic Urology, Bala-Cynwyd
- Keystone Urology Specialists, Lancaster
被験者募集中第1相
18歳以上 · 男性 · 2026/07/09更新 · NCT05413421Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- Thomas Jefferson University, Philadelphia
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
被験者募集中第1相
18歳以上 · 男性 · 2026/07/02更新 · NCT07140900A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Thomas Jefferson University Hospital, Philadelphia
被験者募集中第1/2相
18歳以上 · 男性 · 2026/06/25更新 · NCT06457919Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia
被験者募集中第2相
18歳以上 · 男性 · 2026/06/15更新 · NCT05422911Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- University of Pittsburg Medical Center (UPCM), Pittsburgh
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/11更新 · NCT05283330Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/08更新 · NCT04890613Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Univ of Pittsburgh Medical Center, Pittsburgh
被験者募集中第4相
18歳〜100歳 · 男性 · 2026/06/04更新 · NCT05803941ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。